secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2023-06-12T23:59:59+00:00
Accession:  0001493152-23-020927
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma stockholders elect six directors, ratify auditor at 2023 annual meeting
--------------------------------------------------------------------------------

- All six director nominees elected: Kornberg, Frost, Hassan, Japour, Pfenniger Jr., Rubin; votes ranged from 3.8M to 4.5M for.
- Ratification of Weinberg & Company as independent auditor for FY 2023: 6,594,971 for, 186,279 against.
- Non-binding advisory vote on named executive officer compensation approved: 3,668,840 for, 976,339 against.
- Proposal 4 (adjournment) declared moot due to sufficient votes on prior proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000149315223020927/0001493152-23-020927-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000149315223020927/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-020927

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer